Listen "SEASON 3, EPISODE 6 - Rudy Hovelinck - Going Over the Regulatory Cliff: Accommodating Multiple File Formats "
Episode Synopsis
What is the state of the industry in 2023 in terms of driving towards unified file formats? Is middleware or software to bridge between various components and file formats still necessary and if so for how long? Why do we even have different file formats? Is it a feature or a bug?
Rudy Hovelinck is the CEO of Pathomation, where he directs the company efforts to deliver high quality universal digital pathology software for use in education and biomarker training, life science research and routine diagnostics. His lifelong ambition is to launch products that make a true difference in cancer patient care.
We're going to be talking about unified file formats or the lack thereof; How middleware serves to bridge the gap between various components in the digital pathology pixel pathway; What is involved in regulatory certification of software products in digital pathology and how it benefits customers; What steps are needed in achieving various regulatory certifications such as CE IVD or FDA clearance; What are the risks involved in embarking on such an endeavor and what advice Rudy would have for startups or other young companies seeking to develop software products in a regulated environment.
Rudy Hovelinck is the CEO of Pathomation, where he directs the company efforts to deliver high quality universal digital pathology software for use in education and biomarker training, life science research and routine diagnostics. His lifelong ambition is to launch products that make a true difference in cancer patient care.
We're going to be talking about unified file formats or the lack thereof; How middleware serves to bridge the gap between various components in the digital pathology pixel pathway; What is involved in regulatory certification of software products in digital pathology and how it benefits customers; What steps are needed in achieving various regulatory certifications such as CE IVD or FDA clearance; What are the risks involved in embarking on such an endeavor and what advice Rudy would have for startups or other young companies seeking to develop software products in a regulated environment.
More episodes of the podcast Digital-Pathology-Today
September 2025 Digital Pathology Roundup
01/11/2025
August 2025 Digital Pathology Roundup
30/09/2025
July 2025 Digital Pathology Roundup
29/08/2025
June 2025 Digital Pathology roundup
31/07/2025
May 2025 Digital Pathology Roundup
30/06/2025
April 2025 Digital Pathology Roundup
01/06/2025
March 2025 Digital Pathology Roundup
01/05/2025
February 2025 Digital Pathology Roundup
31/03/2025
January 2025 Digital Pathology Roundup
28/02/2025
2025 Digital Pathology Predictions
24/02/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.